Cardiovascular Prevention
Research & Innovation
Advancing cardiovascular health through prevention, behavioural interventions, and innovative clinical research.
Why Prevention Matters
7+ million
Deaths annually from tobacco use worldwide
1.2 billion
People worldwide still use tobacco products
1 in 2
Canadians who smoke will die from a smoking-related disease
Sources: WHO 2023; Health Canada 2023; Statistics Canada 2022
#1
Smoking remains the leading preventable cause of disease and premature death in Canada
Our Focus
Tobacco & Nicotine Cessation
Cardiovascular Risk Prevention
Digital Health & Remote Care
Implementation & Population Health
Clinical Trials
Our lab leads clinical trials evaluating innovative approaches to cardiovascular prevention and risk reduction. Our research includes smoking and vaping cessation interventions, behavioural support programs, remote monitoring, and technology-enabled models of care designed to improve cardiovascular health and patient outcomes.
Through these studies, we aim to identify practical, scalable strategies that can be integrated into clinical practice and reach patients both within and beyond traditional healthcare settings.